About Us

Message

HOME

>

About Us

>

Message from the Representative

Message from the Representative Director


Contents


Contents



Life is more than the sum of its parts.

Message from the Representative Director

Life is more than the sum of its parts.

It is a complex system in which molecules, cells, tissues, the immune system, metabolism, and many other elements interact across multiple levels to maintain homeostasis. At Advalife Science, we build on the rigorous analysis of individual components while viewing life as a complex system, and we work to discover and develop novel drug candidates.

The foundation of our research and development lies in bringing phenomena observed in clinical practice back into research as new hypotheses, and scientifically investigating the biological mechanisms that may underlie them. By creating a continuous cycle between research, drug discovery, and clinical practice, we carry the knowledge gained forward to new questions and advance it toward intellectual property, manufacturing and CMC, and clinical development. Throughout this process, we remain committed to clearly distinguishing what is known from what is not yet known, and to approaching every piece of data with scientific integrity.

Science born in Japan, brought to the world.
Knowledge from around the world, translated into new medicines and the future of healthcare.

General Incorporated Association Advalife Science
Masatomo Abe, Representative Director

代表理事 阿部 純丈


Profile

Name

Masatomo Abe

Position

Representative Director, General Incorporated Association Advalife Science

Career

・

Pharmacia K.K. (now Pfizer Japan Inc.)

・

Representative Director, Iberica Holdings Co., Ltd.

・

Part-time Lecturer, Faculty of Medicine and Graduate School of Medical Sciences, Kyushu University (ten years)

・

Representative Director, General Incorporated Association Advalife Science

For thirty years Masatomo Abe has worked in the clinical development of medicines, particularly in immunomodulators, antibody drugs and oncology. He has taken part in the clinical development and launch of several medicines, including medicines now used as first-line treatments in clinical practice.

Working closely with the Ministry of Education, Culture, Sports, Science and Technology, Masatomo Abe also established the Biostatistics Center at Kurume University.This was the first university department in Japan for clinical statistics to be founded within a medical faculty, and its mission has been to train biostatisticians and so strengthen life science in Japan.

Continuing to take on challenges is what leads to growth and to progress — and to better options for the people we serve.

Contact us

Enquiries about the organisation, research collaboration and business partnerships, and media requests are all received here.